Biodesix Debt To Equity from 2010 to 2025

BDSX Stock  USD 0.83  0.02  2.35%   
Biodesix Debt To Equity yearly trend continues to be fairly stable with very little volatility. Debt To Equity will likely drop to 2.14 in 2025. Debt To Equity is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. View All Fundamentals
 
Debt To Equity  
First Reported
2010-12-31
Previous Quarter
2.96876796
Current Value
2.14
Quarterly Volatility
3.34202448
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.9 M, as well as many indicators such as Price To Sales Ratio of 2.64, Dividend Yield of 0.0 or PTB Ratio of 7.36. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Latest Biodesix's Debt To Equity Growth Pattern

Below is the plot of the Debt To Equity of Biodesix over the last few years. It is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. Biodesix's Debt To Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.20 %10 Years Trend
Slightly volatile
   Debt To Equity   
       Timeline  

Biodesix Debt To Equity Regression Statistics

Arithmetic Mean1.24
Geometric Mean0.34
Coefficient Of Variation268.97
Mean Deviation1.87
Median(0.12)
Standard Deviation3.34
Sample Variance11.17
Range13.4087
R-Value0.51
Mean Square Error8.84
R-Squared0.26
Significance0.04
Slope0.36
Total Sum of Squares167.54

Biodesix Debt To Equity History

2025 2.14
2024 2.97
2023 13.25
2022 1.55
2021 0.51
2020 0.67
2019 -0.16

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's Debt To Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Debt To Equity 2.97  2.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.